Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Option Care HealthOPCH -0.29%72 3-Year EBITDA Growth Rate is 11.90% as of Jun. 2026, which is at its 10-year median of 11.90. GuruFocus rates OPCH with a GF Score™ of 72/100 and a GF Value™ of $39.63 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 526 Healthcare Providers & Services companies, Option Care Health ranks better than 54.18% on this metric.
During the past 12 months, Option Care Health's average EBITDA Per Share Growth Rate was 8.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 11.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 20.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Option Care Health was 73.50% per year. The lowest was -46.90% per year. And the median was 11.90% per year.
Option Care Health (NAS:OPCH) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Option Care Health 3-Year EBITDA Growth Rate Related Terms
OPCH vs NHC, BKD, ACHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Option Care Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Option Care Health 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Option Care Health's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Option Care Health's 3-Year EBITDA Growth Rate falls into.
Option Care Health 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 11.90% mean?
Option Care Health (OPCH) has a 3-Year EBITDA Growth Rate of 11.90% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Option Care Health and its competitors. This is near median its historical median of 11.90. According to the industry distribution chart, Option Care Health ranks #241 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 45.8%.
Is Option Care Health's 3-Year EBITDA Growth Rate too high?
Option Care Health's current 3-Year EBITDA Growth Rate of 11.90% is near median its 10-year median of 11.90. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Option Care Health's value of 11.90% is 18.4% above this industry median. Based on the distribution chart, Option Care Health ranks #241 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Option Care Health has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Option Care Health's 3-Year EBITDA Growth Rate compare to NHC and BKD?
According to the Healthcare Providers & Services industry distribution chart, Option Care Health ranks #241 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Option Care Health in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. Option Care Health's value of 11.90% is 18.4% above this benchmark. While the company's 10-year median is 11.90 vs. the industry median of 10.05, Option Care Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Option Care Health's current 3-Year EBITDA Growth Rate of 11.90% is 18.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Option Care Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Option Care Health's current 3-Year EBITDA Growth Rate is 11.90%, which is near median its own 10-year median of 11.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Care Health stock overvalued right now?
Based on GuruFocus' analysis, Option Care Health (OPCH) is currently considered Significantly Undervalued. The stock's GF Value™ is $39.63, compared to a current price of $23.91 — trading 39.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 11.90%, which is near median its 10-year median of 11.90 and 18.4% above the Healthcare Providers & Services industry median of 10.05. Option Care Health's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Option Care Health (OPCH), the current 3-Year EBITDA Growth Rate is 11.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Option Care Health (OPCH) Overvalued in 2026?
Based on GuruFocus' analysis, Option Care Health stock appears to be undervalued.
The current stock price of $23.91 is trading 39.7% below its estimated GF Value™ of $39.63.
GuruFocus considers Option Care Health to be Significantly Undervalued.
Key valuation signals for OPCH:
3-Year EBITDA Growth Rate: 11.90% (near median its 10-year median of 11.90)
GF Value™: $39.63 vs. price of $23.91 (39.7% below fair value)
Industry Position: 18.4% above the Healthcare Providers & Services median (#241 of 526)
No single metric tells the full story. See the OPCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
72GF Score
Get the complete analysis for OPCH
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPCH has been successfully added to your 
